Kim Rodriguez was the President, CEO and Co-Founder of Acessa Health, Inc. who successfully sold to Hologic. Prior to Acessa Health, she served as president & CEO of Halt Medical. Prior to that, senior vice president of the Vascular Intervention business unit at Spectranetics, a publicly-traded cardiovascular company acquired by Royal Philips for $2.2B. Over the course of a 20+ year career in cardiology, radiology, vascular surgery, neurology and women’s health, Kim has been involved in the commercialization of dozens of innovative medtech technologies and M&A transactions. Kim received her Executive MBA at the University of Southern California Marshall School of Business and B.S. in Management from Pepperdine University. We discussed being a FemTech exit, uterine fibroids and hysterectomies.

Check out the Acessa Health at www.acessaprocedure.com

Rate, Review & Subscribe!